Immune-related disease tolerance is an important defense strategy that facilitates the maintenance of health in organs and tissues that are commonly colonized by bacteria. Immune tolerance to dysbiotic, tooth-borne biofilms is a poorly understood yet clinically relevant concept in the immunopathological mechanisms that are involved in the pathogenesis of periodontitis, particularly those related to neutrophil and macrophage responses. In periodontal health, neutrophils and macrophages respond to the formation of pathogenic bacterial biofilms by the production of bactericidal reactive oxygen species (ROS). However, when released in excess, ROS cause tissue damage and exacerbate inflammation. To counter these destructive responses, many cell types, including neutrophils and macrophages, launch a dedicated antioxidant system that limits the cell and tissue-damaging effects of ROS. The expression of antioxidants is primarily regulated by genetic response elements in their promoters. Here we consider the roles of nuclear factor erythroid 2-related factor (NrF2), a transcription factor, and other key regulators of antioxidants. The concept of disease tolerance, neutrophil and macrophagegenerated oxidative stress, and their relationship to the pathogenesis of periodontitis is reviewed. We focus on the regulation of NrF2 and recent evidence suggesting that NrF2 plays a central role in host protection against tissue destruction in periodontitis.
Introduction
Nuclear factor erythroid 2-related factor 2 (NrF2) is a key transcription factor that regulates antioxidant expression and is downregulated in neutrophils from patients with advanced periodontitis ). Here we discuss the concept of immune-related disease tolerance (Medzhitov et al. 2012 ) in which the host tolerates pathogens as a defense strategy to maintain health in a bacteria-rich environment, of which periodontal tissues are a poignant example.
The clinical significance of immune tolerance to dysbiotic biofilms in periodontitis is intriguing as host-related immunopathological mechanisms are major contributors to the progression of periodontitis. The normal neutrophil-mediated response to bacteria involves the production of reactive oxygen species (ROS). While the primary role of ROS is in bacterial killing, in excess these molecules promote tissue damage and can initiate a pronounced inflammatory response. Cells (including neutrophils and macrophages) exhibit dedicated systems to minimize the effects of cell and tissue damage arising from ROS. One critical system for prevention of ROSassociated damage involves the expression of antioxidants, which are primarily regulated by the master antioxidant response element downstream of the NrF2 transcription factor. Below, we review the concept of disease tolerance and the role of neutrophils and macrophages in ROS generation and the pathogenesis of periodontitis. We consider transcriptional regulation of antioxidants and evidence suggesting that over the long term, antioxidants could be key targets for treatment of periodontitis.
Disease Tolerance
In a general sense, the innate immune system of mammals has evolved to eliminate invading pathogens. However, in some diseases and in some individuals, an excessive inflammatory response leads to tissue damage and disease (Landzberg et al. 2015 ). An improved understanding of disease tolerance could enable development of new treatments for infections in which immune tolerance is important for maintenance of health (Medzhitov et al. 2012) , and this seems to be particularly important for prevention of tissue destruction in periodontitis. In this context, immune tolerance may be defined as the dampening of the negative effects of infections on the host but without directly affecting the pathogen burden. Earlier work on immune tolerance to specific bacterial infections, which employed inbred mouse strains, demonstrated that tolerance is genetically determined (Råberg et al. 2007 ). Stress response genes, and specifically those genes that are involved in the management of oxidative stress, are key regulators of immune tolerance to bacterial pathogens (Larsen et al. 2010 ). Furthermore, and as discussed below, immune-mediated oxidative stress is a critical component of the pathogenesis of periodontitis. This 
Role of Neutrophils and Macrophages in Periodontal Health and Disease
Neutrophils (polymorphonuclear leukocytes [PMNs] ) and macrophages traffic through and are normally found in the healthy marginal gingiva, from where they migrate and enter the gingival sulcus. PMNs play a key role in initiating periodontitis in the gingival lamina propria and in the pocket epithelium, where they are the predominant inflammatory cell in early periodontal lesions. Early, nonspecific PMN and macrophage responses to dental biofilms provide cofactors that are used by pathogenic bacteria such as Porphyromonas gingivalis to initiate dysbiosis, setting the stage for the transition from gingivitis to periodontitis.
Deviations of physiological PMN and macrophage activity from normal responses include a broad range of disturbances that manifest as the altered production and release of bactericidal factors (Shaddox et al. 2010) , disturbed PMN and macrophage recruitment to inflammatory sites, or the impaired function or hyperreactivity of superoxide production (Hasturk et al. 2012 ). These disturbances are frequently associated with disruption of periodontal tissue homeostasis, which results in tissue destruction and loss of clinical attachment (Hajishengallis 2014) . The importance of tight regulation of PMN and macrophage metabolism for maintaining periodontal health has been deduced from large numbers of clinical studies of aggressive periodontitis (Shaddox et al. 2010; Fredman et al. 2011 ). Below we focus on PMNs and, where appropriate, consider the role of macrophages in regulation of ROS activity.
Neutrophils and ROS in Periodontal Diseases
Two distinct PMN subsets have been identified in the periodontium. Para-inflammatory PMNs are found in the healthy periodontium while proinflammatory PMNs are more abundant in advanced periodontitis. Compared to para-inflammatory PMNs, proinflammatory PMNs exhibit increased degranulation, expression of matrix adhesion receptors, and bacterial phagocytosis (Fine et al. 2016) . Notably, para-inflammatory PMNs in healthy periodontium express elevated levels of several antioxidant genes that are downstream of the NrF2 pathway . Consistent with these data, proinflammatory PMNs exhibit high levels of ROS production, which is consistent with decreased levels of antioxidants and increased PMN extracellular trap formation (Fine et al. 2016 ). Furthermore, proinflammatory PMNs express genes that prolong cell survival and enhance chemotaxis (Lakschevitz et al. 2015) . Collectively, these data suggest that NrF2 may be an important regulator of PMNs that dampens their responses to pathogenic biofilms. This property may enhance tolerance to biofilms by PMNs from healthy subjects but is diminished in patients susceptible to periodontitis.
Although gingival crevicular PMNs can phagocytose bacteria in the gingival crevice, this may not be the predominant mechanism for periodontal protection. When exposed to pathogens, PMNs employ efficient oxidation systems that kill phagocytosed bacteria, mainly by production of ROS, which include superoxide radicals, hydrogen peroxide, hydroxyl radicals, and hypochlorous acid. These molecules cause tissue damage by oxidation of proteins, DNA, and lipids. Oxidation of thiol groups on adjacent cysteines in some proteins can lead to the formation of disulfide bridges, which alter protein function. Therefore, ROS may act as a double-edged sword: they are required for bacterial killing but have the potential to damage cells and tissues.
Tightly regulated ROS generation by PMNs may not be essential for maintenance of periodontal health. In patients with chronic granulomatous disease, there is greatly diminished production of ROS because of a defective nicotinamide adenine dinucleotide phosphate (NADPH) oxidase system. These patients exhibit only a small increased risk of gingivitis, and there is reduced susceptibility to periodontitis (Winkelstein et al. 2000) . Furthermore, oxidase-null mice are resistant to P. gingivalis infections and P. gingivalis-induced periodontitis (Mydel et al. 2006) , which is consistent with the notion that normal levels of ROS production may not prevent periodontitis. Notably, patients with hyperactive ROS responses are more susceptible to periodontitis than patients with normal ROS responses (Johnstone et al. 2007; Aboodi et al. 2011) , indicating that tight regulation of ROS levels is important for periodontal health.
The relationships between gingival crevicular PMNs, bacterially induced ROS generation, and biofilms associated with periodontal health are poorly understood. Similar to intestinal bacteria, the oral bacteria associated with periodontal health play a role in regulating immune tolerance and may prevent hyperactivation of the host immune system. Conceivably, the biofilms associated with health promote a disease-tolerant, PMN phenotype that provides periodontal protection but without the generation of excessive inflammation (Kotas and Medzhitov 2015) . The net effect of interpatient variations in the relative abundance of PMN phenotypes could affect the severity of inflammation, the abundance of oxidant generation, and the resultant extent of tissue destruction in patients with periodontitis (Fine et al. 2016 ).
Oxidative Stress
Free radicals are unstable molecules because of their unpaired electron. Antioxidants counteract the process of oxidation by supplying a molecule that bonds with the unpaired electrons of free radicals and prevents or delays oxidation reactions and neutralizes free radicals. Superoxide dismutase (also known as Orgotein, Ontosein, and Palosein) was the first antioxidant identified as a potential anti-inflammatory agent (McGinness et al. 1978) . In this context, during phagocytosis, PMNs and macrophages produce superoxide radicals, which promote oxidative stress that mediates depolymerization of the abundant extracellular matrix molecule, hyaluronic acid (McCord et al. 1980 ). The ability of superoxide dismutase to prevent oxidative stress-associated damage of hyaluronic acid supported the idea that superoxide dismutase could be used as an anti-inflammatory and that ROS may be critical for the inflammatory process (McCord et al. 1980 ).
As described above, oxidative stress refers to the imbalance between the relative abundance of oxidants and of antioxidants (superoxide dismutase, catalase, glutathione [GSH] peroxidases) that are required to restore oxidant balance in the local system. ROS detoxification is conducted by the antioxidant system, which comprises antioxidant enzymes such as superoxide dismutase, catalase, GSH peroxidase, and GSH reductase (Table 1) . Nonenzymatic antioxidants include GSH, vitamin E, ubiquinol (coenzyme Q), ascorbic acid, and thioredoxin. These antioxidants chemically neutralize ROS. For example, oxygen radicals are converted to hydrogen peroxide by superoxide dismutase. Hydrogen peroxide is then converted by catalase or GSH peroxidase to water. The expression of these antioxidants is regulated by antioxidant response elements that lie downstream of the transcription factor, NrF2.
NrF2 and Regulation of Antioxidants
NrF2 is a basic leucine zipper transcription factor that regulates gene transcription of antioxidants and phase II detoxifying enzymes. NrF2 comprises 6 highly conserved domains (Neh1-6), which are required for molecular interactions that mediate NrF2 signaling (Fig. 1 ). NrF2 plays a central role in oxidative and electrophilic insults and may contribute to the control of inflammatory injury because of its affinity for antioxidant response elements (AREs) in the promoter of essential antioxidant and detoxifying enzyme genes . Under basal conditions, NrF2 is bound to Keap1, a cytoskeletal binding protein, which mediates the constant shuttling of NrF2 to the ubiquitin-mediated proteasome system (UPS) for degradation, thereby keeping NrF2 protein levels low and preventing transcription of unneeded antioxidant genes (Fig. 2) .
Keap1 is an adaptor protein, which binds to NrF2 and promotes its degradation and acts as the primary NrF2 regulatory mechanism (Harder et al. 2015) . Two Keap1 molecules are responsible for recognition of NrF2 through 2 key motifs in the Neh2 domain of NrF2, which is located in its N-terminus. A small proportion of NrF2 escapes the inhibitory complex and accumulates in the nucleus to mediate basal ARE-dependent gene expression, thereby maintaining cellular redox homeostasis (Kansanen et al. 2013) .
During periods of oxidative stress, cytoplasmic NrF2 is released from Keap1, which allows it to be translocated into the nucleus and transcriptionally regulate antioxidant genes 
Antioxidants
Functions/Clinical Significance References Glutathione (GSH) Catalyzes conversion of hydrogen peroxide to water; major source of protection against oxidative stress. Impaired GSH homeostasis has been associated with a number of neurological, cardiovascular, and pulmonary diseases. Restoring GSH levels has also revealed to reduce the hyperactivity of circulating neutrophils associated with chronic periodontitis in vitro.
Dias et al. 2013
Superoxide dismutase (SOD)
First line of defense against free radicals; catalyzes the reduction of the superoxide anion radical into hydrogen peroxide. The therapeutic potential of SOD has been explored as a treatment agent for inflammatory disorders, including rheumatoid arthritis and osteoarthritis.
Yasui and Baba 2006
Catalase (CAT) Transforms hydrogen peroxide into water and oxygen. Reduced catalase levels have been associated with various reactive oxygen species-mediated pathologies such as atherosclerosis, schizophrenia, and the development of diabetes.
Goyal and Basak 2010
Glutathione peroxidase (GxP)
Transforms hydrogen peroxide into water to limit its harmful effects; GPx-1 has been linked to the development and prevention of diseases such as cancer, diabetes, and cardiovascular disease.
Lubos et al. 2011
Figure 1. Domain structures of nuclear factor erythroid 2-related factor (NrF2) and Keap1. NrF2 contains 6 highly conserved domains, Neh1-6. Neh1 contains a bZip motif that mediates dimerization with small Maf proteins and is required for DNA binding. Neh2 contains the DLG and ETGE motifs, which control the interaction with Keap1. The Neh6 domain contains the phosphodegron that is recognized by β-TrCP1 adaptor protein and mediates degradation of NrF2 in the nucleus. Neh3-5 function as transactivation domains. In Keap1, the intervening region (IVR) separates the BTB domain from the Kelch domain. The BTB domain mediates homodimerization of Keap1 and its binding with Cullin3 (Cul3). The Kelch domain mediates the interaction with Neh2. A few of the cysteine residues on Keap1 have been shown for their importance as sensors for electrophiles and oxidants. Cys151 is required for activation of NrF2 while Cys273 and Cys288 are required for suppression of NrF2. This figure is based on Kansanen et al. (2013) .
( Table 2) . Activation of transcription is achieved through the ability of NrF2 to bind to AREs by heterodimerizing with Maf proteins, which recognize the AREs in the promoter region of target genes such as NAD(P)H quinone oxidoreductase 1 (NQO1), heme oxygenase 1 (HMOX1), glutamate-cysteine ligase (GCL), and glutathione S-transferases (GSTs) (Kansanen et al. 2013 ). Subsequently, several key factors are recruited for the transcription and synthesis of these critical enzymes. The activation of NrF2 is essential for regulation of gene expression to maintain cellular redox homeostasis (Harder et al. 2015) . There are also separate, protein regulatory mechanisms that may activate NrF2 by disrupting the NrF2-Keap1 interaction. These involve protein p62, which can disrupt NrF2-Keap1 interactions to increase nuclear NrF2. p62 binds to Keap1 and interacts with the DLG and ETGE motifs of NrF2, thereby competing with NrF2 for Keap1 binding sites. NrF2 will subsequently stabilize, leading to the accumulation of nuclear NrF2 (Kansanen et al. 2013) . p21 is a protein that has been attributed with the reduction of NrF2 ubiquitination. It interferes with Keap1-NrF2 interactions by binding to Keap1 to compete for the DLG motif of NrF2 and contributes to the positive regulation of NrF2 (Stepkowski and Kruszewski 2011).
Posttranslational regulation of
NrF2 may involve protein kinases (Table 2) , which phosphorylate NrF2 and affect its activation. The kinases implicated in NrF2 phosphorylation include PKC, PI3K/ Akt, Gsk-3b, and JNK (Bryan et al. 2013 ). In addition to the ability of NrF2 to regulate transcription of antioxidant genes, the expression of NrF2 itself is also regulated as outlined below (Table 2) . 2. NrF2 expression can be regulated transcriptionally, which uses an AHR-XRE-dependent pathway and a K-Ras-ERK-dependent pathway. For example, oncogenic K-Ras upregulates NrF2 messenger RNA (mRNA) levels, which may explain why oncogenic K-Ras mutations lead to chemoresistant tumors (Harder et al. 2015) . 3. NrF2 expression can be regulated at the translational level by a Keap1-independent mechanism that involves microRNAs (miRNAs). NrF2 mRNA levels are inversely correlated with miR-28 expression, and the expression of miR-28 alone can reduce NrF2 mRNA and protein levels (Yang et al. 2011 ). MicroRNAs regulate genes involved through base pairing with mRNAs, as well as inhibit gene expression through mRNA degradation and inhibition of protein translation (Yang et al. 2011 ). The molecular mechanisms by which miR-28 inhibits NrF2 mRNA expression involve the ability of miR-28 to regulate the 3′ untranslated region (3′-UTR) of NrF2 mRNA; miR-28 reduces wild-type NrF2 3′-UTR luciferase reporter activity, and the repression is eliminated upon mutation of the miR-28 targeting seed sequence within the NrF2 3′-UTR. In addition, overexpression of miR-28 decreases endogenous NrF2 mRNA and protein expression (Yang et al. 2011 ).
Other Transcriptional Regulators of Antioxidants
While NrF2 is the master regulator of antioxidants in cells, antioxidant transcriptional regulation can be regulated by other proteins . FOXO is a family of transcription factors characterized by a forkhead domain and winged-helix DNA binding motif and involved in cellular defense by regulating genes for antioxidant proteins, including SOD2 (Klotz et al. 2015) . SOD2 reduces oxygen free radicals into hydrogen peroxide, GSH peroxidases, and catalase. FOXO3a regulates the generation of peroxisomal catalase. Alternatively, hydrogen peroxide may be neutralized through other pathways via thioredoxin and GSH, whose generation is regulated by mitochondrial FOXOs (peroxiredoxin-3 and peroxiredoxin-5) and cytoplasmic FOXO (GSH peroxidase-1), respectively (Olmos et al. 2013) .
FOXO activation in target cells may decrease host susceptibility to periodontitis. Deletion of FOXO1 in the dendritic cells of experimental mice increases bone loss by 50% compared with controls and increases levels of interleukin (IL)-1, IL-17, and receptor activator of nuclear factor kappa-B ligand (RANKL) . These cytokines stimulate osteoclast formation, promote bone resorption, and are elevated in the gingival crevicular fluid of individuals with periodontitis. Deletion of FOXO1 in dendritic cells downregulates genes involved in dendritic cell migration, including the αν integrin, the β3 integrin, and matrix metalloproteinase-2 (MMP-2), which likely contributes to the reduced recruitment of dendritic cells to oral mucosal epithelium .
FOXO transcription factors are tightly regulated by posttranslational modifications. These modifications include phosphorylation, acetylation, and ubiquitination; FOXO nuclear localization and degradation via phosphoinositide-3-kinase/ AKT/IKK or RAS/mitogen-activated protein kinase phosphorylation at different FOXO sites; and interaction with coregulators and antioxidant peroxiredoxins in a redox-sensitive manner Klotz et al. 2015) . FOXOs are promising drug targets for enhancing the generation and activity of antioxidant enzymes that are involved in inflammatory diseases such as periodontitis.
The sirtuin family of deacetylases has been shown to activate SOD2, resulting in the reduction in oxidative stress (Chen et al. 2011 ) and the suppression of inflammation-mediated bone loss in a mouse collagen-induced arthritis model ). Sirtiun1 has also been shown to suppress osteoclastogenesis through the direct activation of FOXO proteins through their deacetylation (Kim et al. 2015) . This suggests that sirtuins may also hold promise as therapeutics for periodontal inflammation mediated bone loss.
A Role for NrF2 in Periodontitis
Periodontitis is an inflammatory disease characterized by the destruction of periodontal tissues, which is mediated by toothborne, pathogenic bacterial biofilms adjacent to the dentogingival junction (Dahiya et al. 2013 ). During disease progression, Posttranslation Phosphorylation Different kinases can phosphorylate the serine, threonine, and tyrosine residues on NrF2, leading to its nuclear translocation or degradation. Rojo et al. 2012 Oxidative regulation Proteasomal degradation The Keap1-NrF2 interaction facilitates the proteasomal degradation and high turnover of NrF2 protein. Itoh et al. 2003 Protein interference Disruption of NrF2-Keap interaction by p62 and a separate p21 process Both p62 and p21 mediate increased nuclear NrF2. Kansanen et al. 2013 persistent proinflammatory responses promote the recruitment of PMNs to the marginal lesion. At these sites, there is a sustained release of PMN enzymes and ROS into the extracellular environment ( Fig. 3) (Dahiya et al. 2013 ). These responses, which are an attempt to control the growth of pathogenic biofilms, promote episodic destruction of tooth-supporting tissues.
In the context of progressive periodontal lesions, what is the role of PMN-related oxidative stress? Is NrF2 a possible drug target for enhancing antioxidant production and potentially diminishing periodontal destruction? Oxidative stress is an important contributor to periodontal destruction in periodontitis . Compared to healthy patients, in chronic periodontitis patients who are refractory to conventional periodontal therapy, their oral PMNs produce markedly higher levels of ROS and they exhibit greater loss of periodontal attachment. Excessive production of ROS and a relative deficiency of antioxidants cause increased oxidative damage to proteins in the periodontium, lipid peroxidation in plasma, saliva, and gingival crevicular fluid; these alterations are associated with disease severity (Kurita-Ochiai et al. 2015) . Individuals with advanced periodontitis exhibit lower levels of total antioxidant capacity in plasma (TAOC) compared with controls (Chapple, Brock, et al. 2007) , and plasma levels of TAOC are inversely associated with periodontitis ). This association is enhanced in patients with more severe disease (Baser et al. 2015) . Thus, excessive ROS production by PMNs and compromised plasma antioxidant capacity suggest a more global, oxidative stress environment in patients with periodontitis .
The control of oxidative stress in healthy periodontium suggests that NrF2 plays an important role to preserve periodontal tissues in the face of constant bacterial, neutrophil, and macrophage interactions (Hasturk et al. 2012) , which is a critical element of periodontal disease tolerance. In studies of the oxidative state of local and systemic PMNs from chronic periodontitis patients, downregulation of the NrF2 pathway and subsequent inhibition of antioxidant production in oral PMNs were In health, tightly apposed gingival tissues help to maintain the epithelial attachment. The oral cavity harbors numerous nonpathogenic bacteria, which stimulate neutrophils to enter the gingival crevice and epithelium. Acting as the first line of defense, neutrophils respond to the bacterial biofilm by producing reactive oxygen species (ROS) via the metabolic pathway of oxidative burst. In periodontal health, a balance is maintained between the amounts of ROS generated and the antioxidant defense systems, whereby the nuclear factor erythroid 2-related factor (NrF2) pathway is activated and antioxidants are released to neutralize the ROS. Conceivably, the bacterial biofilms associated with periodontal health promote a disease-tolerant, para-inflammatory polymorphonuclear leukocyte (PMN) phenotype that provides periodontal protection without the generation of excessive inflammation. (B) In periodontitis, bacteria accumulate on the tooth surface and infect the adjacent epithelium and connective tissue, causing an increased recruitment of neutrophils into the periodontal pocket. The increase in neutrophil infiltrate is associated with a downregulation of the NrF2 pathway and subsequent inhibition of antioxidant production, leading to an excess production of ROS. As a result, the high levels of ROS lead to an increase in neutrophil extracellular trap (NET) formation, releasing granular proteins that bind to and kill bacteria. This may correspond to a proinflammatory PMN phenotype that is incapable of sufficiently upregulating the antioxidant pathway. associated with increased recruitment of oral PMNs and more advanced periodontitis ( Fig. 3) . These results may be explained by the ability of oxidative stress to blunt NrF2 signaling in periodontitis. Twenty-four genes were identified in the NrF2-mediated oxidative stress response pathway, which were downregulated in PMNs from patients with chronic periodontitis. Downstream of NrF2, the levels of oral PMN superoxide dismutase 1 and catalase were decreased in severe chronic periodontitis, despite increased oral PMN recruitment. The levels of 8-hydroxy-deoxyguanosine were increased in periodontal lesions of NrF2-deficient mice, indicating high oxidative damage ). Furthermore, NrF2 knockout mice exhibited increased local oxidative damage and alveolar bone and attachment loss at sites with chronic periodontitis ), suggesting that the PMNs in chronic periodontitis patients may be primed for a low antioxidant response, which results in increased oxidative tissue damage. This finding in NrF2 knockout mice is also consistent with the idea that NrF2 could also play a critical role in bone resorption mediated by osteoclasts. It has been shown that osteoclastic bone resorption is substantially promoted in Nrf2-deficient osteoclast precursor cells compared with WT cells (Hyeon et al. 2013 ) and that ROS are critical promoters of osteoclastogenesis (Kanzaki et al. 2014; Kang and Kim 2016) . Further support for a role of NrF2 in periodontal protection was found in Keap1 luciferase reporter mice, which show increased NrF2 nuclear localization in inflamed periodontal tissues (Kataoka et al. 2016) .
Adjuvant antioxidant therapy is a promising approach for clinical management of periodontitis (Muniz et al. 2015) . While administering antioxidant enzymes such as superoxide dismutase has been proposed (Table 1) , clinical trials in osteoarthritis have shown that intra-articular injections of SOD are not as efficacious as activation of NrF2 to inhibit oxidative stress and related pathophysiological states (McIlwain et al. 1989 ). This is relevant in periodontitis because NrF2 activation affects the expression of hundreds of antioxidant gene products that are involved in protection against oxidants and free radicals (Table  3) . Hence, by activating NrF2 systemically and harnessing its function as an antioxidant, NrF2 activation could block tissue destruction in periodontitis .
Resveratrol, a potent activator of NrF2, prevents alveolar bone loss in a rat periodontitis model by attenuation of the inflammatory response and reduction of osteoclastogenesis (Bhattarai et al. 2016) . NrF2 also induces anti-inflammatory responses in P. gingivalis-stimulated macrophages (Park et al. 2011 ).
Conclusion
Current evidence indicates that NrF2 plays a protective role in many human diseases, including periodontitis. NrF2 can upregulate NrF2-associated antioxidant and detoxification enzymes, which enhances cytoprotective effects such as decreased inflammatory signaling and oxidative damage in tissues Sima et al. 2016) . Accordingly, NrF2 activation may be a viable adjuvant in therapeutic protection against periodontitis.
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